Z16.33

Clinical Causes: Repeated or prolonged use of antiviral medications, leading to selective pressure on the virus Inadequate dosing or poor adherence to prescribed therapy, allowing resistant strains to emerge Genetic mutations within the virus that alter targets of antiviral drugs, reducing their effectiveness Transmission of already resistant viral strains from person to person Incomplete suppression of viral replication during treatment, fostering resistance development

Key Symptoms: Lack of improvement in symptoms despite ongoing antiviral therapy Worsening or persistent symptoms similar to initial infection Emergence of new symptoms indicating possible treatment failure Laboratory evidence of viral breakthrough or increased viral load Potential side effects or adverse reactions from alternative medications used due to resistance

Diagnosis Path: Diagnosis of antiviral resistance involves laboratory testing and clinical evaluation. Key methods include: - Viral load monitoring to assess treatment effectiveness - Genotypic assays to identify specific resistance mutations in viral genes - Phenotypic assays that test the virus's susceptibility to antiviral agents - Regular clinical assessments to observe any changes in symptoms or disease progression Medical professionals interpret these results to determine resistance and adjust treatment plans accordingly.

Treatment Protocols: Managing resistance to antiviral drugs typically involves several strategies, such as: - Switching to alternative antiviral medications with different mechanisms of action - Combining multiple drugs to reduce the likelihood of resistance development - Optimizing drug dosages and ensuring adherence to therapy - Monitoring viral load regularly to detect treatment failure early - Supporting research efforts for new antivirals targeting resistant strains It is essential for healthcare providers to tailor treatment plans based on resistance testing results while considering patient-specific factors and disease severity.